Commit To Purchase Oruka Therapeutics At $35, Earn 57.5% Annualized Using Options

Oruka Therapeutics (ORKA) is trading at $57.19/share and the article suggests cautious investors consider selling put options as an alternative to buying at the market price. It flags an ‘‘interesting put contract’’ (details truncated) as a way to potentially acquire shares at a lower effective price or earn premium; no company fundamentals, catalysts, or option specifics were provided.

Analysis

Oruka Therapeutics (ORKA) is trading at $57.19/share and the article suggests cautious investors consider selling put options as an alternative to buying at the market price. It flags an ‘‘interesting put contract’’ (details truncated) as a way to potentially acquire shares at a lower effective price or earn premium; no company fundamentals, catalysts, or option specifics were provided.